[spanish] Más de setecientos expertos de todo el mundo participarán en la primera edición del Congreso de las Sociedades de Bioquímica y Biología Molecular de Francia, Portugal y España (FEBS3+) que se celebrará en Barcelona del 23 al 26 de octubre.

The first results from an IMPC study of hearing loss in laboratory mice has revealed novel genes related to hearing loss that will help unravel the complex genetics of this common condition. These new insights will help identify new therapeutic targets that may lead to the development of new treatments.

[hear-it.org] Professional musicians experience hearing loss, tinnitus and ear pain, an Iranian study finds.

The 2017-2018 Keystone Symposia conference season is about to begin and we want to bring to your attention the following conferences that you may find of interest.

Nobelprize.org welcomes this year’s 12 new Nobel Laureates: three in Physics, three in Chemistry, three in Physiology or Medicine, one in Literature, one in Peace – this year an organisation – and one new Laureate in Economic Sciences. All of them are introduced at Nobelprize.org with presentations, videos, photos and interviews.

Spiral Therapeutics, Inc., a biopharmaceutical company developing first-in-class therapies targeting inner ear disorders, reported positive feedback from the US Food and Drug Administration (FDA) in response to Spiral’s first pre-Investigational New Drug (pre-IND) package submission.

This is the newsletter of the European Commission’s eHealth, Wellbeing and Ageing team. It is hosted by the Digital Agenda for Europe Newsroom. In this issue: Policy, Research and Events.